CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6,036 enrolled
Drug / intervention
Questionnaireother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02773836
NCT02773836N/ACompleted

European Regulatory Science on Tobacco: Policy Implementation to Reduce Lung Diseases (EUREST-PLUS)

European Network For Smoking and Tobacco Prevention·observational·Posted May 16, 2016·Updated Jun 3, 2019

In Brief

An observational study evaluating Questionnaire for Tobacco Dependence. Completed, enrolled 6,036 participants across 1 site.

Detailed Summary

The main objective of EUREST-PLUS is to monitor and evaluate the impact of the Tobacco Products Directive (TPD) within the context of FCTC ratification at an EU level. The investigators specific objectives, within WorkPackage 2 and Workpackage 3 are: To evaluate the psychosocial and behavioral impact of TPD implementation and FCTC implementation, through the creation of a cohort study of adult smokers in 6 European Member States (EU MS), Germany, Greece, Hungary, Poland, Romania, Spain; (total n=6000) in a pre- vs. post-TPD study design. EUREST-PLUS is funded through the European Union's Horizon 2020 research and innovation programme under grant agreement No 681109

Study Details

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 16, 2016
Enrollment StartJun 15, 2016
Primary CompletionSep 12, 2016
Study CompletionMay 6, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 10.1 years ago

Interventions

Questionnaireother

Questionnaire: To evaluate the impact of the implementation of the EU Tobacco Products Directive (TPD) and Framework Convention on Tobacco Control (FCTC)